Orchestra BioMed Hldgs (NASDAQ:OBIO) just reported results for the first quarter of 2024.
- Orchestra BioMed Hldgs reported earnings per share of -38 cents. This was above the analyst estimate for EPS of -41 cents.
- The company reported revenue of $620,000.
- This was 34.04% worse than the analyst estimate for revenue of $940,000.